Lysine N6-monooxygenase
RxNorm 391473
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 391473 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Lysine N6-monooxygenase.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
L-lysine 6-monooxygenase (NADPH)
(Atom ID: 1632162)
SY
Synonym (SY):
L-lysine 6-monooxygenase (reduced nicotinamide adenine dinucleotide phosphate)
(Atom ID: 5940038)
FN
Full form of descriptor (FN):
L-lysine 6-monooxygenase (reduced nicotinamide adenine dinucleotide phosphate) (substance)
(Atom ID: 5940039)
SY
Synonym (SY):
Lysine N6-hydroxylase
(Atom ID: 1632164)
SY